Results 161 to 170 of about 15,173 (297)
El diseño de un plan de formación continua
Libro completo: http://hdl.handle.net/10115 ...
Rey Moreno, Carlos +5 more
openaire +7 more sources
Mental illness, mental health, and mental well-being. [PDF]
VanderWeele TJ +9 more
europepmc +1 more source
Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina +11 more
wiley +1 more source
[Social pain: a clinically relevant literature review in primary care]. [PDF]
Ordóñez Azuara YG +3 more
europepmc +1 more source
Posterior Cortical Atrophy in the Asia‐Pacific: A Report From the PCA Asian Workgroup
ABSTRACT Objective Posterior Cortical Atrophy (PCA) is a distinct dementia syndrome primarily affecting spatial abilities and visual processing. It is associated with degeneration in the posterior part of the brain. PCA is subclassified into PCA‐pure and PCA‐plus syndromes based on consensus criteria.
Yuttachai Likitjaroen +11 more
wiley +1 more source
Beyond the Scale: Obesity as a Structural Driver of Refractory Hypertension. [PDF]
Tibirica E.
europepmc +1 more source
Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes
ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini +28 more
wiley +1 more source
Long-term control of refractory acrodermatitis continua of Hallopeau with subcutaneous spesolimab: A case report. [PDF]
Wagner JN +4 more
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Project Continua: Female Biography for the Digital World
Scholarly efforts to recover the important contributions of earlier learned women have intensified with inspiring yet challenging results. Lack of interconnectivity among scholars in the Humanities, routinely separated by academic disciplines and ...
Walker, Gina Luria, Whipp, Koren
core

